Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SH-SY5Y Cell Line In Vitro Models for Parkinson Disease Research—Old Practice for New Trends
Octavian Costin Ioghen, Laura Cristina Ceafalan, Bogdan Popescu
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Unraveling brain diseases: The promise of brain-on-a-chip models
Letizia Cerutti, Martina Brofiga
Journal of Neuroscience Methods (2024) Vol. 405, pp. 110105-110105
Open Access | Times Cited: 7
Transdermal delivery of resveratrol loaded solid lipid nanoparticle as a microneedle patch: a novel approach for the treatment of Parkinson’s disease
Akshay Bandiwadekar, Jobin Jose, Gopika Gopan, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 7
The Protective Effect of Docosahexaenoic Acid on Mitochondria in SH-SY5Y Model of Rotenone-Induced Toxicity
Britta Eggers, Jennifer Stepien, Anne-Katrin Reker, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 29-29
Open Access
Two- and Three-Dimensional In Vitro Models of Parkinson’s and Alzheimer’s Diseases: State-of-the-Art and Applications
Cristina Solana‐Manrique, Ana María Sánchez‐Pérez, Nuria Paricio, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 620-620
Open Access
Identifying potential genes driving ferroptosis in the substantia nigra and dopaminergic neurons in Parkinson's disease
Arunaloke Chakrabarti, Sonia Verma
Molecular and Cellular Neuroscience (2025) Vol. 132, pp. 103993-103993
Closed Access
Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism
О.А. Бунеева, A. E. Medvedev
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1248-1248
Open Access
STAT4 targets KISS1 to inhibit the oxidative damage, inflammation and neuronal apoptosis in experimental PD models by inactivating the MAPK pathway
Xiaolei Zhang, Yu Wang, Jia Lv
Neurochemistry International (2024) Vol. 175, pp. 105683-105683
Closed Access | Times Cited: 5
N -acetylcysteine increases dopamine release and prevents the deleterious effects of 6-OHDA on the expression of VMAT2, α-synuclein, and tyrosine hydroxylase
Roine El‐Habta, Sara af Bjerkén, Ana Virel
Neurological Research (2024) Vol. 46, Iss. 5, pp. 406-415
Open Access | Times Cited: 4
Schisandra chinensis (Turcz.) Baill neutral polysaccharides alleviate Parkinson's disease via effectively activating MCL-1 expression regulation of autophagy signaling
Siyi Wang, Mengmeng Li, Li Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 134952-134952
Closed Access | Times Cited: 4
Multiomic Profiling and Neuroprotective Bioactivity of Salvia Hairy Root-Derived Extracellular Vesicles in a Cellular Model of Parkinson’s Disease
Vincenzo Vestuto, Marisa Conte, Mariapia Vietri, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9373-9393
Open Access | Times Cited: 3
The SH-SY5Y cell line: a valuable tool for Parkinson’s disease drug discovery
Manisha Pandey, Varnita Karmakar, Ankit Majie, et al.
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 3, pp. 303-316
Closed Access | Times Cited: 8
Both Enantiomers of 2-Hydroxyglutarate Modulate the Metabolism of Cultured Human Neuroblastoma Cells
Eduard Gondáš, Eva Baranovičová, Peter Bystrický, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Stable knockdown of Drp1 improves retinoic acid-BDNF-induced neuronal differentiation through global transcriptomic changes and results in reduced phosphorylation of ERK1/2 independently of DUSP1 and 6
Marvi Ghani, Peleg Zohar, Gyula Ujlaki, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Protective Effects of Cannabidiol (CBD) against Qxidative Stress, but Not Excitotoxic-Related Neuronal Cell Damage—An In Vitro Study
Danuta Jantas, Monika Leśkiewicz, Magdalena Regulska, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 564-564
Open Access | Times Cited: 2
Both Enantiomers of 2-Hydroxyglutarate Modulate the Metabolism of Cultured Human Neuroblastoma Cells
Eduard Gondáš, Eva Baranovičová, Peter Bystrický, et al.
Neurochemical Research (2024) Vol. 49, Iss. 9, pp. 2480-2490
Open Access | Times Cited: 2
Experimental Models in Parkinson’s Disease: Advantages and Disadvantages
Öznur Altunlu, Esma Topatan, Ziadoon Al-yaqoobi, et al.
Deleted Journal (2024) Vol. 2, Iss. 2, pp. 80-87
Open Access | Times Cited: 2
In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders
Dalinda Isabel Sánchez-Vidaña, Jingjing Li, Samuel Abokyi, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7
Untargeted metabolomics reveal pathways associated with neuroprotective effect of oxyresveratrol in SH-SY5Y cells
Nureesun Mahamud, Phanit Songvut, Chawanphat Muangnoi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Modulation of TRPV1 and TRPA1 Channels Function by Sea Anemones’ Peptides Enhances the Viability of SH-SY5Y Cell Model of Parkinson’s Disease
Yuliya S. Kolesova, Yulia Yu. Stroylova, Ekaterina E. Maleeva, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 368-368
Open Access | Times Cited: 5
Exploring the therapeutic potential of Rab11: A comprehensive study on its effectiveness in alleviating rotenone-induced molecular pathogenesis of Parkinson's disease in SH-SY5Y cells and its synergistic application with L-DOPA in Drosophila models
Pooja Rai, Sada N. Pandey, Jagat Kumar Roy
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130219-130219
Closed Access | Times Cited: 1
Neuroprotective Effects of Polysaccharides and Gallic Acid from Amauroderma rugosum against 6-OHDA-Induced Toxicity in SH-SY5Y Cells
Panthakarn Rangsinth, Nattaporn Pattarachotanant, Wen Wang, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 953-953
Open Access | Times Cited: 1
Extraction of malva sylvestris seed oil by soxhlet method and alginate/chitosan microencapsulation with a new method: Investigation of its cytotoxic effects on human neuroblastoma cell line (SH-SY5Y)
Hasan Ulusal, Fatma Ulusal, Ş. Burçak Dağli, et al.
Journal of Radiation Research and Applied Sciences (2024) Vol. 17, Iss. 2, pp. 100875-100875
Open Access | Times Cited: 1
Proteomics-based identification of biomarkers reflecting endogenous and exogenous exposure to the advanced glycation end product precursor methylglyoxal in SH-SY5Y human neuroblastoma cells
Liang Zheng, Sjef Boeren, Chen Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132859-132859
Open Access | Times Cited: 1
Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects
Ashutosh Pareek, R. L. Singhal, Aaushi Pareek, et al.
Life Sciences (2024) Vol. 355, pp. 123010-123010
Open Access | Times Cited: 1
Formononetin Exerts Neuroprotection in Parkinson’s Disease via the Activation of the Nrf2 Signaling Pathway
Xiaotong Wang, Nianxin Kang, Ying Liu, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5364-5364
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top